RegWardenFDA facility compliance records
Recall

Class II — Ambu Inc.

Recalling firmAmbu A/S
Registered facilityAMBU INNOVATION GMBH (the firm's only registered facility)
ClassificationClass II
StatusOngoing
ReasonMultiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lithium-ion battery in the device combust leading to smoke and flames
ProductAmbu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualization devices, portable endoscopy system. Catalog No: 405011000
Quantity2689 units
DistributionNationwide
Initiated2023-07-21
Classified2023-09-22
Recall numberZ-2628-2023
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Ambu Inc. (Z-2628-2023).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/92886/

Not open yet

Alerts for Ambu A/S

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.